Thrombosis is the formation of solid blood clots (thrombi) in the blood vessels which threatens to disrupt normal blood circulation. What poses the greatest threat to the human body in thrombus formation is a condition in which a thrombus suddenly breaks free from the wall of a vessel to become
The drug candidate FK Laboratories has come up with represents the next generation of highly specific direct thrombin inhibitor, the solution most widely used to deal with the pathology. «The medicine under development is offering a range of key advantages, including oral administering, no toxicity, and high specificity," Primer Capital executive director Elizaveta Rozhdestvenskaya said.
The developer will funnel the Primer Capital investment, as well as a $524,000 Minister of Education and Science grant received earlier, into a series of preclinical trials.
Currently